Merck KGaA (MKKGY)
31.09
+0.02
(+0.06%)
USD |
OTCM |
Apr 19, 15:59
Merck Cash from Financing (TTM): -1.875B for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -1.875B |
September 30, 2023 | -1.400B |
June 30, 2023 | -1.979B |
March 31, 2023 | -1.153B |
December 31, 2022 | -1.640B |
September 30, 2022 | -1.452B |
June 30, 2022 | -1.850B |
March 31, 2022 | -3.323B |
December 31, 2021 | -2.963B |
September 30, 2021 | -4.148B |
June 30, 2021 | -3.272B |
March 31, 2021 | -2.329B |
December 31, 2020 | -1.738B |
September 30, 2020 | -454.02M |
June 30, 2020 | 998.36M |
March 31, 2020 | 2.731B |
December 31, 2019 | 2.129B |
September 30, 2019 | -237.15M |
June 30, 2019 | -1.586B |
March 31, 2019 | -3.336B |
December 31, 2018 | -3.336B |
September 30, 2018 | -1.249B |
June 30, 2018 | -1.952B |
March 31, 2018 | -1.813B |
December 31, 2017 | -2.118B |
Date | Value |
---|---|
September 30, 2017 | -1.841B |
June 30, 2017 | -1.583B |
March 31, 2017 | -1.790B |
December 31, 2016 | -2.112B |
September 30, 2016 | 1.316B |
June 30, 2016 | 4.563B |
March 31, 2016 | 4.737B |
December 31, 2015 | 7.950B |
September 30, 2015 | 6.829B |
June 30, 2015 | 4.511B |
March 31, 2015 | 3.583B |
December 31, 2014 | 1.011B |
September 30, 2014 | -1.148B |
June 30, 2014 | -2.299B |
March 31, 2014 | -1.274B |
December 31, 2013 | -1.425B |
September 30, 2013 | -2.055B |
June 30, 2013 | -1.128B |
March 31, 2013 | -1.258B |
December 31, 2012 | -1.953B |
September 30, 2012 | -1.329B |
June 30, 2012 | -1.337B |
March 31, 2012 | -1.170B |
December 31, 2011 | -535.56M |
September 30, 2011 | -1.274B |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-4.148B
Minimum
Sep 2021
2.731B
Maximum
Mar 2020
-1.344B
Average
-1.640B
Median
Dec 2022
Cash from Financing (TTM) Benchmarks
Affimed NV | -6.734M |
InflaRx NV | 57.36M |
MorphoSys AG | -- |
BioNTech SE | -842.92M |
Immatics NV | 91.50M |